RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection
Description
The SARS-CoV-2 pandemic has underscored the need for rapidly employable prophylactic and antiviral treatments against emerging viruses. Targeted stimulation of antiviral innate immune receptors can trigger a broad antiviral response that also acts
